OPHTALMOCARE
ActiveOPHTALMOCARE has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €229k and a net result of €253k. Equity is growing by ~53.3% per year across the filed fiscal years. Its solvency ranks better than 42% of 19904 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
83
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency84▼-6
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days acceptable
Liquidity ample (current ratio 1.65 against 3.88 in 2023; short-term debt: 28.8% and cash: 9.7% of total assets), and 40.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
59.1%
Return on assets
65.5%
Age of the figures
20 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 15-10-2025, 76 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
not confirmed
2024
76 d late
2023
on the day
2022
30 d late
2021
31 d late
2020
31 d late
2019
46 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€229k▼ 13.8%
2023 · €265k
2019: €-42k
2020: €-9k
2021: €89k
2022: €148k
2023: €265k
2019 → 2024
Total assets
€387k▼ 4.7%
2023 · €406k
2019: €337k
2020: €348k
2021: €401k
2022: €411k
2023: €406k
2019 → 2024
Net result
€253k▲ 117%
2023 · €117k
2019: €-52k
2020: €33k
2021: €98k
2022: €59k
2023: €117k
2019 → 2024
Working capital
€72k▼ 52.2%
2023 · €151k
2019: €-361k
2020: €-243k
2021: €-199k
2022: €26k
2023: €151k
2019 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€-9k-€89k€148k▲ 66.5%€265k▲ 78.6%€229k▼ 13.8%
Operating result€36k-€122k▲ 238%€77k▼ 37.1%€151k▲ 96.5%€336k▲ 123%
Net result€33k-€98k▲ 195%€59k▼ 39.3%€117k▲ 96.9%€253k▲ 117%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 123% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €387k
Fixed assets
€203k▲ 0.5%
Current assets
€184k▼ 9.8%
Equity and liabilities €387k
Equity
€229k▼ 13.8%
Debt
€158k▲ 12.5%
The debt ratio rises from 34.6% to 40.9%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€381k▲
2023 · €200k
Cash flow
€299k▲
2023 · €166k
Solvency
59.1%▼
2023 · 65.4%
Current ratio
1.65▼
2023 · 3.88
Quick ratio
1.65▼
2023 · 3.88
Debt / equity
0.69▲
2023 · 0.53
ROE
110.8%▲
2023 · 44.0%
ROA
65.5%▲
2023 · 28.8%
Interest coverage
267.08▲
2023 · 98.81
Debt
€158k▲
2023 · €140k
Debt ≤ 1 year
€111k▲
2023 · €52k
Debt > 1 year
€47k▼
2023 · €88k
Income taxes
€82k▲
2023 · €33k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€406k€387k▼
Fixed assets21/28€202k€203k▲
Intangible fixed assets21€161k€129k▼
Tangible fixed assets22/27€41k€74k▲
Plant, machinery and equipment23-€46k
Furniture and vehicles24€41k€28k▼
Financial fixed assets28€30€30=
Current assets29/58€204k€184k▼
Amounts receivable within one year40/41€1k€31k▲
Trade receivables40€1k€8k▲
Other amounts receivable41-€22k
Current investments50/53€93k€112k▲
Cash at bank and in hand54/58€83k€37k▼
Deferred charges and accrued income490/1€27k€3k▼
Equity and liabilities
Total equity and liabilities10/49€406k€387k▼
Equity10/15€265k€229k▼
Contributions10/11€10k€10k=
Profit (loss) carried forward14€255k€219k▼
Amounts payable17/49€140k€158k▲
Amounts payable after more than one year17€88k€47k▼
Financial debts170/4€88k€47k▼
Amounts payable within one year42/48€52k€111k▲
Current portion of amounts payable after more than one year42€41k€41k▲
Trade debts44€3k€2k▼
Suppliers440/4€3k€2k▼
Taxes, remuneration and social security45€5k€33k▲
Taxes450/3€3k€30k▲
Remuneration and social security454/9€3k€3k=
Other amounts payable47/48€4k€35k▲
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€49k€45k▼
Other operating charges640/8€462€2k▲
Gross operating margin9900€200k€383k▲
Operating profit (loss)9901€151k€336k▲
Financial income75/76B€524€749▲
Recurring financial income75€524€749▲
Financial charges65/66B€2k€1k▼
Recurring financial charges65€2k€1k▼
Profit (loss) for the period before taxes9903€149k€335k▲
Income taxes67/77€33k€82k▲
Profit (loss) for the period9904€117k€253k▲
Profit (loss) for the period to be appropriated9905€117k€253k▲
Appropriation of the result
Profit (loss) to be appropriated9906€255k€509k▲
Profit (loss) brought forward from the previous period14P€138k€255k▲
Profit to be distributed694/7-€290k
Return on contributions (dividend)694-€290k
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
15-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 76 days late
2024
31-12
Financial
Highest result since 2019net €253k ▲117%
Operating result €336k, net result €253k, both a record.
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Liquidity triplescurrent ratio 3.88
Current ratio from 1.20 to 3.88; short-term debt falls from €133k to €52k.
31-12
Financial
Equity above €200kEq €265k ▲78.6%
4 profitable years in a row build equity to €265k.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
2022
31-12
Financial
Liquidity quadruplescurrent ratio 1.20
Current ratio from 0.34 to 1.20; short-term debt falls from €301k to €133k.
31-12
Financial
Equity above €100kEq €148k ▲66.5%
3 profitable years in a row build equity to €148k.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-12
Financial
Back to profitnet €33k
Net result €33k after one loss-making year.
15-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 46 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Waterloo · 1 establishment unit since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Drève Richelle 161 K1410 WaterlooGround area
1.0 ha
Building footprint
1,772 m²
Volume, LiDAR
33,713 m³
Parcel 25763M0621/00F000, Wallonia · tallest building 22.9 m, ±6 floors. Linked by address, not a title deed.
1 establishment unit
OPHTALMOCARE
since 20192.296.953.367
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25763M0621/00F000indicative | Wallonia | 1.0 ha | 1 · 1,772 m² | 22.9 m · 6 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
0 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
BillaLom
BE 0802.655.204
Tienen · Eq €229k
LEQUENNE
BE 0453.073.736
Tournai · Eq €229k
DOKTER LUC ALGOED, NEUROLOOG
BE 0666.877.572
Gent · Eq €229k
Dr. Deepanjali Custers
BE 0778.695.709
Dilsen-Stokkem · Eq €228k
SOLANCA
BE 0795.167.891
Leuven · Eq €228k
Of 16,617 companies in sector 86220 we hold annual accounts for 7,970. 6,656 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-12-2019
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.